+91-8668442535

Freezing of Gait Treatment Market By Treatment Type (Oral Dopaminergic Medication, Wearable and Walking Aid Devices, Deep Brain Stimulation), By End User Segment (Hospitals, Clinics, Research and Academic Institutes) - Growth, Future Prospects, and Competitive Analysis, 2019 - 2027

"Freezing of gait treatment market to exhibit productive growth during the forecast period" 

The global freezing of gait treatment market is growing effectually, expected to grow at a CAGR of 7.2%. Globally, increasing prevalence of Parkinson's disease has significantly increased the revenue of oral dopaminergic medications. FDA approval for new drugs, and promising pipeline products in the equipment and devices segment in the Parkinson's disease industry are driving the overall growth freezing of gait treatment market globally. 

Market Synopsis

Freezing of Gait Treatment Market 

Get a sample copy for more information

"Oral dopaminergic medication segment is expected to register higher growth by the end of 2027" 

Levodopa (Inbrija™, by Acorda Therapeutics), along with carbidopa, remains the optimum standard of symptomatic treatment for (FoG) Parkinson disease orally. In Dec 2018, the U.S. FDA approved Inbrija™ for the alternating treatment of “OFF” incidents in people with Parkinson’s disease who are already treated with levodopa/carbidopa. It is a novel approach for the treatment of OFF periods in PD. Advanced pipeline products in the wearable and walking aid segment will show promising growth in near future. For e.g. In the CES 2018 conference in Las Vegas, a Chinese company named GYENNO showcased its gait aid equipment package, mainly helps to escape gait freeze in Parkinson’s patients. Additionally, Kyungpook National University showcased android based gait-aid system by using smart glasses with wearable sensors.

Freezing of Gait Treatment Market

Get a sample copy for more information

"Increasing admissions for freezing of gait in the hospital segment to witness a significant CAGR"

Increasing chronic Parkinson’s disease (PD) along with significant admissions in the hospitals internationally are notable factors expected for the growth of the market. According to FDA and other research studies, symptomatic and neuroprotective therapies are opted for PD in hospitals. Deep brain stimulation procedures along with helpful brain exercises are also adopted in the end user segment, showed promising results in recent time. Moreover, increasing elderly population along with increasing admissions is escalating the growth in the end-user segment. Moreover, lunch of new medications and equipment in the U.S. market and internationally along with increased funding for PD patient care for the administrations of freezing of gait treatment on a global scale will drive the growth during the forecast period.

Freezing of Gait Treatment Market

Get a sample copy for more information

"Increasing population, new FDA approval and the presence of top players holds the U.S. in dominant position" 

In 2018, the U.S contributed maximum revenue share in the freezing of gait treatment market due to the rising prevalence of PD. Key prime factors include rising awareness about new medications and therapies, FDA approvals for new drugs, and rising PD care services along with enhanced reimbursement structure will drive the demand in near future. Emerging nations always suffer the burden of chronic diseases. Nevertheless, there is no significant treatment targeted towards freezing of gait in PD, but strong pipeline drugs and products along with the approval for levodopa will further enhance the growth on a global scale. 

Freezing of Gait Treatment Market

"Increased research and development with strong product pipelines in the developed regions" 

Major players in the freezing of gait treatment market are Acorda Therapeutics, The Michael J. Fox Foundation, GYENNO, National University of Ireland, Galway (NUI Galway), Kyungpook National University, Republic of Korea, MedEXO Robotics, TABLE Teva Pharmaceuticals and others. Major organizations and research centers are developing progressive technologies with new technology expansion in the wearable and walking aids systems, electronic brain implants and other stimulators for freezing of gait treatment on a global scale.

Freezing of Gait Treatment Market

Historical & Forecast Period 

This study report represents analysis for each segment from 2017 to 2027 considering 2018 to be the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period from 2019 to 2027.

Report Scope by Segments

Market Segmentation  

ATTRIBUTE DETAILS
Research Period  2017-2027
Base Year 2018
Forecast Period  2019-2027
Historical Year  2017
Unit  USD Million
Segmentation

 Treatment Type (2017–2027; US$ Mn)
 • Oral Dopaminergic Medication (Inbrija - levodopa inhalation   powder)
 • Wearable and Walking Aid Devices
 • Deep Brain Stimulation
 • Others (Brain Implants)

 End-User Segment (2017–2027; US$ Mn)
 • Hospitals
 • Clinics
 • Research and Academic Institutes

 Geography Segment (2017–2027; US$ Mn)
 • North America (U.S., Canada)
 • Europe (U.K., Germany, Rest of Europe)
 • Asia Pacific (Japan, China, Rest of Asia Pacific)
 • Latin America (Brazil, Mexico, Rest of Latin America)
 • Middle East & Africa (GCC, Rest of Middle East & Africa)

The current report also comprehends qualitative and qualitative market valuation factors such as key market drivers, market trends, restraints and opportunities that gives a better market understanding of the overall freezing of gait treatment market. Additionally, the global report also comprises graphical representation of competitive landscape based on their market initiatives and strategies, product portfolio and business strengths.

Key questions answered in this report 

  • What are the current market trends and dynamics in the freezing of gait treatment market and valuable opportunities for emerging players?
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which treatment type segment holds a larger market share and why?
  • Are low and middle-income economies investing in the freezing of gait treatment market?
  • What is the market trend and dynamics in emerging markets such as Asia Pacific, Latin America and Middle East & Africa?
Choose License Type
Budget Buying
Executive Summary - Brief Global Market Size - Current & Forecast
Regional Market Size - North America
Country Market Size - US
Company Profile – 1
Trusted By
Godaddy
Published Date:  Jun 2019
Category:  Pharmaceuticals
Report ID:   59720
Report Format:   PDF
Pages:   120
Rating:    4.4 (58)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
+91-8668442535
24/7 Research Support